Loading clinical trials...
Loading clinical trials...
The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the k...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tranzyme, Inc.
NCT07224321 · Type 1 Diabetes Mellitus
NCT07222137 · Diabetes Mellitus, Type 1
NCT07536516 · Diabetes Mellitus
NCT07340320 · Type II Diabetes Mellitus
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
University of Kansas Medical Center
Kansas City, Kansas
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Temple University Health Sciences Center
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions